Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based quadruple therapy with minocycline for Helicobacter pylori infection
ChiCTR2300074596Phase 4Recruiting
- Sponsor
- The Fifth People's Hospital of Huai'an
- Start
- Aug 2023
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of minocycline, vonoprazan, clarithromycin, furazolidone, amoxicillin and 1 more in Helicobacter pylori infection (4 arms), sponsored by The Fifth People's Hospital of Huai'an. Primary endpoint: Hp eradication rate. Started Aug 2023; status: recruiting.
02
Drugs
minocyclinevonoprazanclarithromycinfurazolidoneamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2300074596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074596.